Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

Completed

• Conditions: Covid19; Health Care Worker

• Registration Number: NCT04845984
• Lead Sponsor: Centre Hospitalier Annecy Genevois

Brief Summary

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Detailed Description

In France during the first wave of the pandemic, 30,230 symptomatic healthcare workers had been reported positive. Yet, the prevalence of the infection in French healthcare workers remains unknown as it mostly reflect symptomatic infections.

Also, the prevalence of infection was reported being higher in male healthcare workers, and in those having patients' facing roles. However, the impact of the level of exposure to SARS-CoV-2, the use of personal protective equipment and hospital organization to prevent infection and spread remains unclear.

Our study aims to report the seroprevalence of SARS-CoV-2 infection among French healthcare workers after the first wave of the pandemic. It also aims to explore the impact of the type of occupations and the level of exposure to the viruses on the seroprevalence of infection.

Study Timeline

• Study Start: 2020-09-01
• Primary Completion: 2021-01-15
• Study Completion: 2021-01-15
• Status Verified: 2021-03
• Study First Submitted: 2021-03-02
• Study First Submitted QC: 2021-04-12
• Last Update Submitted: 2021-04-12
• Study First Posted: 2021-04-15
• Last Update Posted: 2021-04-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3500

Inclusion Criteria

• Hospital staff employee
• Employed in one of the participating centers
• Volunteers to perform SARS-CoV-2 serology
• Permanent or occasional staff (temporary workers, short contracts)
• Caregivers or not (medical, paramedical, administrative, technical staff)

Exclusion Criteria

• Staff who are not working at a participating center while participating in the study
• Person under guardianship or curatorship
• Opposition to data collection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SARS-CoV-2 prevalency among hospital health care professionals	Day 1	Number of Health Care Worker with an antibody test (IgG) positive for SARS-CoV2

Trial Locations

Locations (1)

Ch Annecy Genevois; 🇫🇷 Pringy, France